Mutant HSP70 reverses autoimmune depigmentation in vitiligo. - Wikidata - awgldk - TriplyDB

Mutant HSP70 reverses autoimmune depigmentation in vitiligo.

Mutant HSP70 reverses autoimmune depigmentation in vitiligo.

http://www.wikidata.org/entity/Q37551330

about

New approaches for predicting T cell-mediated drug reactions: A role for inducible and potentially preventable autoimmunity A central role for inducible heat-shock protein 70 in autoimmune vitiligo Trends in Regenerative Medicine: Repigmentation in Vitiligo Through Melanocyte Stem Cell Mobilization CXCL10 is critical for the progression and maintenance of depigmentation in a mouse model of vitiligo.Interferon-γ induces senescence in normal human melanocytes.Simvastatin prevents and reverses depigmentation in a mouse model of vitiligo Vitiligo treatment update.Cellular stress and innate inflammation in organ-specific autoimmunity: lessons learned from vitiligo.CCL22 to Activate Treg Migration and Suppress Depigmentation in Vitiligo Preferential secretion of inducible HSP70 by vitiligo melanocytes under stress Innate immune mechanisms in vitiligo: danger from within.Understanding mechanisms of autoimmunity through translational research in vitiligo.Understanding autoimmunity of vitiligo and alopecia areata.HSP70 potentiates interferon-alpha production by plasmacytoid dendritic cells: relevance for cutaneous lupus and vitiligo pathogenesis.Synthetic drugs for the treatment of vitiligo: a patent review (2010-2015).Vitiligo Pathogenesis and Emerging Treatments.Vitiligo: Focus on Clinical Aspects, Immunopathogenesis, and Therapy.Vitiligo and alopecia areata: apples and oranges?A new era of vitiligo research and treatment.Bilobalide protection of normal human melanocytes from hydrogen peroxide-induced oxidative damage via promotion of antioxidase expression and inhibition of endoplasmic reticulum stress.Time for a patient-oriented outcome in vitiligo: the vitiligo noticeability scale.Association of HSPA1B SNP rs6457452 with Alopecia Areata in the Korean population.A direct link between MITF, innate immunity, and hair graying.Vitiligo Type I interferon signature in the initiation of the immune response in vitiligo

P2860

Q26800973-A52551FD-9183-4A71-8F52-8499A3DDC6F3 Q26823593-692042CC-6683-4385-8286-49EFBA0F2A5D Q33784208-9A2FE83C-CE28-4353-B9FE-40CBA20B6F36 Q33864128-4FE8F151-C5CC-467E-AC04-6DC266966A40 Q35134926-99281A30-A3A3-4E56-9020-2BC038DF06E3 Q35196424-96260AC5-6E34-47DA-B8C0-1F09041BD7F5 Q35510227-E34C51F9-CEA0-4875-B5AC-317E2E4374A0 Q36389114-E79A358A-A6D0-4132-814B-AC7FDE462BD6 Q37299737-96D1632F-75D4-4479-BD29-B2AFB8B4B70B Q37626557-17ABD9CF-0E68-4726-BECA-B619A13CEE78 Q38163168-130E9E20-870C-478A-B2C8-4A6160D7B63F Q38808662-B12CA407-B1DA-4557-BFD5-9FFB6411B987 Q38837287-C9B06167-8E56-45B1-AB48-6F5784B09A40 Q38852458-652F997A-D766-4C63-98E5-5EDCF1E468D2 Q38908708-957473DE-BDFD-447C-A7C4-FAD7010D2488 Q39187086-E0540E19-2B0D-4333-BFEC-DC5DE83EDDEB Q39419931-FF7DB89B-E1C0-43BA-8A29-CF2E839BD4D7 Q41855663-3C140F32-0423-44FE-B09C-A929A8C44E8E Q42134003-146FB6A9-7E2F-4EB9-AA71-EC15583FD1E8 Q46700082-036031B1-5BE2-4447-BB2B-C7AE7D644E8E Q47826853-63025800-9896-4136-8AE3-BCB583D5CE46 Q53305591-C68E830B-5EF2-4E85-9407-BA12F008864A Q54959863-6802F661-EFEF-46FE-9FC2-480C0BC7EEA1 Q56996499-72E11F71-FC53-4FAC-A5F4-BA343B767F05 Q56996562-48863EC2-69D1-421C-8317-416C58531935

P2860

Mutant HSP70 reverses autoimmune depigmentation in vitiligo.

http://www.wikidata.org/entity/Q37551330

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on February 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Mutant HSP70 reverses autoimmune depigmentation in vitiligo.

@en

Mutant HSP70 reverses autoimmune depigmentation in vitiligo.

@nl

type

label

Mutant HSP70 reverses autoimmune depigmentation in vitiligo.

@en

Mutant HSP70 reverses autoimmune depigmentation in vitiligo.

@nl

prefLabel

Mutant HSP70 reverses autoimmune depigmentation in vitiligo.

@en

Mutant HSP70 reverses autoimmune depigmentation in vitiligo.

@nl

P1433

Q37551330-864615C6-6782-4391-B089-F90870F077CB

P1476

Q37551330-678473AB-5355-41B0-9740-E2C5381BA097

P2093

Q37551330-02DBD29E-E6E1-49FB-AB6E-310AA4834DCE

Q37551330-055FFB85-CEB8-46C2-9D39-F31092B7E8EC

Q37551330-0D3DA330-F8E5-4822-AF4F-0D6D28F30813

Q37551330-16915266-F742-4EB7-A933-573FE61992CC

Q37551330-29A20411-D3C8-49CA-A3A2-70221A2D36ED

Q37551330-4EFB5583-00FC-4068-A52C-8228473429BD

Q37551330-601CFDD9-3FD6-4663-83F5-E2517ED63072

Q37551330-63BBB822-BF4C-4435-B574-BA30305EDC71

Q37551330-700BACDC-77EB-4CE3-A943-7E80FE706B83

Q37551330-7737CF12-6498-47D8-BEE8-37602428F840

P2860

Q37551330-0193E53D-B45B-4933-B861-C98FD116AF9D

Q37551330-21C3119F-F524-456F-A0DB-A7F14FBC6459

Q37551330-26F86869-27E3-43C3-8A49-AE86F55BAAE0

Q37551330-2B0FBB14-26D0-4C88-8DAB-A775EA48FC77

Q37551330-34D660E7-6C3D-4DC1-9576-EF07CA59BEEF

Q37551330-36904755-93FC-4618-9ED8-99DD436ED32F

Q37551330-49497F4F-8B82-4386-A37C-5A75848ECF04

Q37551330-4D6C72A8-1A85-44BD-9DBB-03135C47E2EE

Q37551330-5073CE83-4884-4DBF-B9F3-5ED686E1BD23

Q37551330-64284948-4F87-4D35-A4A2-72EB68108215

P304

Q37551330-838B798F-46CF-48D2-B557-1E6D39A0E11D

P31

Q37551330-519C80A7-F8C8-4CEF-B568-0D322005D0A5

P356

Q37551330-3C48E16C-6EC5-41CB-B356-C4CAFFD8EF98

P407

Q37551330-109C3898-D2E4-4992-A003-E99DD1171BEA

P433

Q37551330-29E7134E-DA41-4022-9693-E6A50709BB75

P478

Q37551330-486BDF68-71D3-4F09-806C-47E04FB4C515

P577

Q37551330-E0E928F7-9F39-4C15-A60A-D87A69918602

P5875

Q37551330-5989E384-FDA5-454D-BA69-89265A395BE9

P698

Q37551330-AE89A4F7-5B27-42E9-ACFC-F3522DDEBF79

P932

Q37551330-407E3438-9C7C-4BD4-BFD1-79752A127FBF

P356

SCITRANSLMED.3005127

P1433

Science Translational Medicine

P1476

Mutant HSP70 reverses autoimmune depigmentation in vitiligo.

@en

P2093

Ahmad Alamiri

http://www.w3.org/2001/XMLSchema#string

Andreas Overbeck

http://www.w3.org/2001/XMLSchema#string

Andrew T Lacek

http://www.w3.org/2001/XMLSchema#string

Andrew Zloza

http://www.w3.org/2001/XMLSchema#string

Cecele J Denman

http://www.w3.org/2001/XMLSchema#string

Claudia Hernandez

http://www.w3.org/2001/XMLSchema#string

Elizabeth Garrett-Mayer

http://www.w3.org/2001/XMLSchema#string

Erica J Huelsmann

http://www.w3.org/2001/XMLSchema#string

Frederick J Kohlhapp

http://www.w3.org/2001/XMLSchema#string

Howard L Kaufman

http://www.w3.org/2001/XMLSchema#string

P2860

Mechanisms of spatial and temporal development of autoimmune vitiligo in tyrosinase-specific TCR transgenic mice.

Distinct binding sites for the ATPase and substrate-binding domain of human Hsp70 on the cell surface of antigen presenting cells.

Topical treatment and combination approaches for vitiligo: new insights, new developments.

Interaction of heat shock proteins with peptides and antigen presenting cells: chaperoning of the innate and adaptive immune responses.

A symbiotic concept of autoimmunity and tumour immunity: lessons from vitiligo.

Improvement of different vaccine delivery systems for cancer therapy.

Local immune response in skin of generalized vitiligo patients. Destruction of melanocytes is associated with the prominent presence of CLA+ T cells at the perilesional site.

Optimization of a self antigen for presentation of multiple epitopes in cancer immunity

4-Tertiary butyl phenol exposure sensitizes human melanocytes to dendritic cell-mediated killing: relevance to vitiligo.

Self- and nonself-recognition by C-type lectins on dendritic cells.

P304

174ra28

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1126/SCITRANSLMED.3005127

http://www.w3.org/2001/XMLSchema#string

P407

P433

174

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2013-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235750450

http://www.w3.org/2001/XMLSchema#string

P698

23447019

http://www.w3.org/2001/XMLSchema#string

P932

3912753

http://www.w3.org/2001/XMLSchema#string